We are live on ! Find out more
USNA icon

Usana Health Sciences

167 hedge funds and large institutions have $528M invested in Usana Health Sciences in 2022 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 68 increasing their positions, 50 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 50

1.24% more ownership

Funds ownership: 53.26%54.5% (+1.2%)

3% less funds holding

Funds holding: 172167 (-5)

8% less capital invested

Capital invested by funds: $573M → $528M (-$45.5M)

16% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 19

27% less call options, than puts

Call options by funds: $148K | Put options by funds: $202K

Holders
167
Holders Change
-5
Holders Change %
-2.91%
% of All Funds
2.68%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
68
Reduced
50
Closed
19
Calls
$148K
Puts
$202K
Net Calls
-$54K
Net Calls Change
-$37K

USNA Hedge Fund Activity: Q4 2022 in Review

167 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q4 2022, worth a combined $528M — down 7.9% from $573M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of USNA and 16 opened new positions — a net loss of 3 holders — while 50 trimmed existing stakes and 68 added.

The largest buyer was BlackRock, adding an estimated $6.77M. The largest seller was Renaissance Technologies, cutting an estimated $4.49M.

  • 167 institutional investors held Usana Health Sciences (USNA) as of Q4 2022, down from 172 in Q3 2022.
  • Funds reported $528M of Usana Health Sciences stock for Q4 2022, down 7.9% quarter-over-quarter.
  • 16 funds opened new Usana Health Sciences positions in Q4 2022 and 19 closed out, a net change of -3 holders.
  • The largest Usana Health Sciences buyer in Q4 2022 was BlackRock, an estimated $6.77M added.
  • The largest Usana Health Sciences seller in Q4 2022 was Renaissance Technologies, an estimated $4.49M sold.

Based on aggregated 13F filings for Q4 2022.